Filgrastim Completed Phase 3 Trials for Malignant Lymphomas / Cardiac Toxicity Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00002827Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease
NCT00005578Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease